Quercetin Alleviates Breast Cancer-Related Depression by Inhibiting Neutrophil Extracellular Traps via Inhibition of Sphingosine 1-Phosphate/Sphingosine 1-Phosphate Receptor Axis
- PMID: 40313180
- DOI: 10.1002/ptr.8513
Quercetin Alleviates Breast Cancer-Related Depression by Inhibiting Neutrophil Extracellular Traps via Inhibition of Sphingosine 1-Phosphate/Sphingosine 1-Phosphate Receptor Axis
Abstract
Breast cancer is associated with a higher incidence of depression and decreased quality of life. Previous studies have indicated that quercetin can mitigate the advancement of breast cancer-related depression (BCRD); however, the specific mechanism by which quercetin affects BCRD is yet to be determined. In this study, we aimed to examine the effect of quercetin on BCRD and explore the underlying mechanisms. We established a mouse model of BCRD and administered quercetin. LC-MS was used to analyze and determine distinct alterations in metabolites in mouse tumor samples. Polymorphonuclear neutrophils (PMNs) were extracted from mouse femurs and treated with PMA and quercetin/Sphingosine 1-phosphate (S1P). Mouse breast cancer cells 4 T1 were treated with lipopolysaccharides (LPS), neutrophil extracellular traps (NETs) and S1P. Neuronal cells were treated with LPS, NETs, S1P, and Corticosterone. Pearson's correlation coefficient was used to evaluate the relationship between differential metabolites and NETs. Quercetin inhibited NET formation in BCRD mice. In vitro, quercetin reversed NET-induced 4 T1 cell proliferation, migration, and ROS production. Quercetin also reversed the effects of NET-induced 4 T1 cells on neuronal cells. LC-MS analysis demonstrated that quercetin ameliorated the metabolic abnormalities in the tumors of BCRD mice. Pearson's correlation analysis showed that S1P, Oleoyl glycine, N-Arachidonoylglycine, 2, 3-butanediol apiosylglucoside, and tetracosatetraenoyl carnitine levels positively correlated with MPO DNA levels. Furthermore, in vitro, S1P enhanced NET-induced 4 T1 cell proliferation, migration, and ROS production, as well as enhanced NET-induced 4 T1 cell damage to neuronal cells. Quercetin alleviated BCRD by inhibiting NETs via inhibition of the S1P/S1PR axis.
Keywords: breast cancer related with depression; metabolism; neutrophil extracellular trap; quercetin; sphingosine 1‐phosphate.
© 2025 John Wiley & Sons Ltd.
Similar articles
-
Quercetin inhibits neuronal Ferroptosis and promotes immune response by targeting lipid metabolism-related gene PTGS2 to alleviate breast cancer-related depression.Phytomedicine. 2024 Jul 25;130:155560. doi: 10.1016/j.phymed.2024.155560. Epub 2024 Apr 4. Phytomedicine. 2024. PMID: 38815404
-
Quercetin Alleviates the Progression of Breast Cancer-Related Depression via Inhibiting the Pyroptosis and Promoting the Immune Response.Mediators Inflamm. 2022 Mar 3;2022:8011988. doi: 10.1155/2022/8011988. eCollection 2022. Mediators Inflamm. 2022. PMID: 35369029 Free PMC article.
-
Kaempferol Improves Breast Cancer-Related Depression through the COX-2/PGE2 Pathway.Front Biosci (Landmark Ed). 2023 Nov 28;28(11):311. doi: 10.31083/j.fbl2811311. Front Biosci (Landmark Ed). 2023. PMID: 38062826
-
The Importance of Sphingosine Kinase in Breast Cancer: A Potential for Breast Cancer Management.Cureus. 2021 Feb 18;13(2):e13413. doi: 10.7759/cureus.13413. Cureus. 2021. PMID: 33758708 Free PMC article. Review.
-
Sphingosine-1-Phosphate and Its Signal Modulators Alleviate Psoriasis-Like Dermatitis: Preclinical and Clinical Evidence and Possible Mechanisms.Front Immunol. 2021 Dec 21;12:759276. doi: 10.3389/fimmu.2021.759276. eCollection 2021. Front Immunol. 2021. PMID: 34992595 Free PMC article.
Cited by
-
Synthesis and Biological Evaluation of β-Phenylalanine Derivatives Containing Sulphonamide and Azole Moieties as Antiproliferative Candidates in Lung Cancer Models.Molecules. 2025 Aug 7;30(15):3303. doi: 10.3390/molecules30153303. Molecules. 2025. PMID: 40807478 Free PMC article.
-
Neutrophil Spatiotemporal Regulatory Networks: Dual Roles in Tumor Growth Regulation and Metastasis.Biomedicines. 2025 Jun 14;13(6):1473. doi: 10.3390/biomedicines13061473. Biomedicines. 2025. PMID: 40564191 Free PMC article. Review.
References
-
- Agrawal, K., P. Chakraborty, S. Dewanjee, et al. 2023. “Neuropharmacological Interventions of Quercetin and Its Derivatives in Neurological and Psychological Disorders.” Neuroscience & Biobehavioral Reviews 144: 104955.
-
- Arseni, L., R. Sharma, N. Mack, et al. 2023. “Sphingosine‐1‐Phosphate Recruits Macrophages and Microglia and Induces a pro‐Tumorigenic Phenotype That Favors Glioma Progression.” Cancers (Basel) 15, no. 2: 479.
-
- Attar, E. S., V. H. Chaudhari, C. G. Deokar, S. Dyawanapelly, and P. V. Devarajan. 2023. “Nano Drug Delivery Strategies for an Oral Bioenhanced Quercetin Formulation.” European Journal of Drug Metabolism and Pharmacokinetics 48: 495–514.
-
- Cartier, A., and T. Hla. 2019. “Sphingosine 1‐Phosphate: Lipid Signaling in Pathology and Therapy.” Science 366, no. 6463: eaar5551.
-
- Casaril, A. M., M. Domingues, S. R. Bampi, et al. 2020. “The Antioxidant and Immunomodulatory Compound 3‐[(4‐Chlorophenyl)selanyl]‐1‐Methyl‐1H‐Indole Attenuates Depression‐Like Behavior and Cognitive Impairment Developed in a Mouse Model of Breast Tumor.” Brain, Behavior, and Immunity 84: 229–241.
Grants and funding
- 2020NSFC-B001/Hunan Cancer Hospital Climb Plan
- 202103101959/Scientific Research Project of Hunan Provincial Health Commission
- 202204015380/Scientific Research Project of Hunan Provincial Health Commission
- 82104846/National Natural Science Foundation of China
- 82405362/National Natural Science Foundation of China
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous